![]() |
|
|
A De Lean, BF Kilpatrick and MG Caron
This article has been cited by other articles:
![]() |
D. J. Roberts, H. Lin, and P. G. Strange Mechanisms of Agonist Action at D2 Dopamine Receptors Mol. Pharmacol., December 1, 2004; 66(6): 1573 - 1579. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. P. Fitzsimons, F. Monczor, N. Fernandez, C. Shayo, and C. Davio Mepyramine, a Histamine H1 Receptor Inverse Agonist, Binds Preferentially to a G Protein-coupled Form of the Receptor and Sequesters G Protein J. Biol. Chem., August 13, 2004; 279(33): 34431 - 34439. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Kenakin Efficacy as a Vector: the Relative Prevalence and Paucity of Inverse Agonism Mol. Pharmacol., January 1, 2004; 65(1): 2 - 11. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. D. Burris, T. F. Molski, C. Xu, E. Ryan, K. Tottori, T. Kikuchi, F. D. Yocca, and P. B. Molinoff Aripiprazole, a Novel Antipsychotic, Is a High-Affinity Partial Agonist at Human Dopamine D2 Receptors J. Pharmacol. Exp. Ther., July 1, 2002; 302(1): 381 - 389. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Guiramand, J.-P. Montmayeur, J. Ceraline, M. Bhatia, and E. Borrelli Alternative Splicing of the Dopamine D2 Receptor Directs Specificity of Coupling to G-proteins J. Biol. Chem., March 31, 1995; 270(13): 7354 - 7358. [Abstract] [Full Text] [PDF] |
||||